GleamWall
中文EN

MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1823239 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.8%
TTM net income YoY45.8%
TTM EPS YoY47.6%
Revenue 3-yr CAGR-20.2%
Net income 3-yr CAGR—

Margins

Gross margin39.1%
Operating margin-45.4%
Net margin-30.8%
FCF margin-5.9%
EBITDA margin-35.1%

Returns

ROE-29.8%
ROA-9.1%
ROIC (approx.)-27.0%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets43.3%
Debt / equity0.75x
Current ratio4.66x
Interest coverage-4.57x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$45.85M$51.44M$65.84M$49.87M$41.63M$47.40M$46.85M$56.41M
Cost of revenue$29.66M$30.79M$32.14M$37.02M$35.98M$39.63M$39.12M$37.44M
Gross profit$16.19M$20.65M$33.70M$12.84M$5.66M$7.77M$7.72M$19.39M
R&D expense$3.39M$3.70M$3.89M$3.79M$3.84M$4.88M$4.89M$4.56M
SG&A expense$30.50M$32.07M$29.09M$31.58M$35.46M$38.72M$39.56M$41.24M
Operating income-$20.62M-$15.09M-$2.16M-$58.80M-$41.03M-$66.28M-$49.16M-$38.13M
Interest expense$4.03M$4.81M$5.75M$6.55M$6.84M$6.82M$6.78M$11.26M
Pretax income-$24.07M-$21.80M-$6.53M-$63.01M-$45.15M-$74.12M-$52.69M-$46.07M
Income tax-$75,000-$171,000-$151,000$6,000-$92,000-$4.29M$162,000-$7,000
Net income-$13.84M-$12.42M-$3.73M-$35.68M-$25.56M-$39.59M-$29.95M-$26.14M
EBITDA-$14.88M-$9.78M$2.74M-$52.86M-$35.06M-$60.32M-$43.47M-$32.66M
EPS (basic)-0.09-0.08-0.02—-0.18-0.27-0.21—
EPS (diluted)-0.09-0.08-0.02—-0.18-0.27-0.21—
Weighted avg. shares (diluted)149.07M148.00M146.43M—144.68M144.24M143.43M—
Balance sheet
Cash & equivalents$73.02M$70.09M$165.92M$216.89M$243.57M$269.91M$285.05M$322.40M
Receivables$25.71M$31.14M$33.41M$25.50M$22.54M$27.88M$28.49M$38.52M
Inventory$43.25M$41.23M$40.46M$40.49M$45.33M$46.67M$49.77M$50.08M
Current assets$154.00M$155.66M$251.74M$296.25M$325.87M$359.76M$376.28M$429.15M
PP&E, net$135.67M$142.41M$146.93M$151.48M$158.62M$162.73M$166.43M$164.47M
Goodwill$129.43M$129.43M$129.43M$129.43M$129.43M$129.43M$159.88M$159.88M
Intangibles$130.97M$138.38M$144.89M$151.54M$185.88M$193.07M$199.58M$194.96M
Total assets$600.07M$603.75M$713.22M$770.58M$849.19M$896.97M$959.75M$1.01B
Current liabilities$33.06M$38.42M$42.62M$44.92M$61.57M$69.68M$63.16M$56.97M
Short-term debt$1.50M$1.12M$5.44M$5.44M$5.44M$5.44M$5.44M$5.44M
Long-term debt$145.68M$145.98M$235.57M$286.33M$287.38M$288.44M$289.50M$290.49M
Total debt$147.18M$147.10M$241.01M$291.77M$292.82M$293.88M$294.94M$295.93M
Total liabilities$259.90M$248.16M$344.13M$397.87M$417.33M$428.98M$429.48M$431.04M
Shareholders' equity$195.89M$204.62M$211.56M$212.38M$245.44M$265.86M$300.61M$325.29M
Net debt$74.16M$77.01M$75.09M$74.88M$49.25M$23.97M$9.89M-$26.47M
Cash flow statement
Operating cash flow$5.01M$3.99M$8.66M-$22.77M-$15.15M-$10.27M-$9.39M-$14.64M
Capital expenditure$523,000$370,000$4.44M$2.11M$2.93M$2.87M$4.50M$5.85M
Free cash flow$4.49M$3.62M$4.23M-$24.88M-$18.08M-$13.14M-$13.89M-$20.49M
Investing cash flow-$523,000-$370,000-$4.44M-$2.11M-$2.93M-$3.24M-$23.13M-$4.93M
Financing cash flow-$1.57M-$98.98M-$55.23M-$1.82M-$8.25M-$1.53M-$4.90M-$236.19M
Depreciation & amortization$5.74M$5.31M$4.90M$5.93M$5.97M$5.96M$5.69M$5.47M
Stock-based compensation$10.12M$10.21M$6.74M$3.93M$9.06M$6.79M$10.40M$10.54M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.